Peter Wijngaard - Net Worth and Insider Trading
Peter Wijngaard Net Worth
The estimated net worth of Peter Wijngaard is at least $4,703 dollars as of 2024-12-27. Peter Wijngaard is the Director of Hepion Pharmaceuticals Inc and owns about 9,501 shares of Hepion Pharmaceuticals Inc (HEPA) stock worth over $4,703. Details can be seen in Peter Wijngaard's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Wijngaard has not made any transactions after 2023-11-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter Wijngaard
Peter Wijngaard Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Wijngaard owns 2 companies in total, including Hepion Pharmaceuticals Inc (HEPA) , and The Medicines Co (MDCO) .
Click here to see the complete history of Peter Wijngaard’s form 4 insider trades.
Insider Ownership Summary of Peter Wijngaard
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HEPA | Hepion Pharmaceuticals Inc | 2023-11-27 | director |
| MDCO | The Medicines Co | 2020-01-06 | Chief Development Officer |
Peter Wijngaard Latest Holdings Summary
Peter Wijngaard currently owns a total of 1 stock. Peter Wijngaard owns 9,501 shares of Hepion Pharmaceuticals Inc (HEPA) as of November 27, 2023, with a value of $4,703.
Latest Holdings of Peter Wijngaard
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HEPA | Hepion Pharmaceuticals Inc | 2023-11-27 | 9,501 | 0.50 | 4,703 |
Holding Weightings of Peter Wijngaard
Peter Wijngaard Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Wijngaard has made a total of 4 transactions in Hepion Pharmaceuticals Inc (HEPA) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Hepion Pharmaceuticals Inc is the acquisition of 5,000 shares on November 27, 2023, which cost Peter Wijngaard around $15,350.
Insider Trading History of Peter Wijngaard
- 1
Peter Wijngaard Trading Performance
GuruFocus tracks the stock performance after each of Peter Wijngaard's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Wijngaard is -21.22%. GuruFocus also compares Peter Wijngaard's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Wijngaard within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter Wijngaard's insider trading performs compared to the benchmark.
Performance of Peter Wijngaard
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.59 | | | | | |
| Relative Return to S&P 500(%) | 2.67 | | | | | |
Peter Wijngaard Ownership Network
Peter Wijngaard Owned Company Details
What does Hepion Pharmaceuticals Inc do?
Who are the key executives at Hepion Pharmaceuticals Inc?
Peter Wijngaard is the director of Hepion Pharmaceuticals Inc. Other key executives at Hepion Pharmaceuticals Inc include Chief Scientific Officer Robert T Foster , Chief Financial Officer John T Cavan , and director & CEO and President Gary S Jacob .
Hepion Pharmaceuticals Inc (HEPA) Insider Trades Summary
Over the past 18 months, Peter Wijngaard made 2 insider transaction in Hepion Pharmaceuticals Inc (HEPA) with a net purchase of 8,000. Other recent insider transactions involving Hepion Pharmaceuticals Inc (HEPA) include a net purchase of 3,200 shares made by Robert T Foster ,
In summary, during the past 3 months, insiders sold 0 shares of Hepion Pharmaceuticals Inc (HEPA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hepion Pharmaceuticals Inc (HEPA) were sold and 11,200 shares were bought by its insiders, resulting in a net purchase of 11,200 shares.
Hepion Pharmaceuticals Inc (HEPA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hepion Pharmaceuticals Inc Insider Transactions
Peter Wijngaard Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Wijngaard. You might contact Peter Wijngaard via mailing address: 8 Sylvan Way, Parsippany Nj 07054.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
